Guanjiuzhao (Guangdong) Biotechnology Co., Ltd. – Trademark Portfolio
Entity Type: 99
Guanjiuzhao (Guangdong) Biotechnology Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 32 (Light Beverages) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include FLAXWELL. The owner is based in Foshan City, Guangdong Province.
No. 102-402, Unit 2, Building 4, Sheng Yue Yuan, 33rd Road, Shun Ye East Road, Xingtan Town, Shunde District
Foshan City, Guangdong Province 528300 , CN
Showing of trademarks Trademarks
Trademark Classifications
Guanjiuzhao (Guangdong) Biotechnology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages
Frequently Asked Questions
How many trademarks does Guanjiuzhao (Guangdong) Biotechnology Co., Ltd. have?
Guanjiuzhao (Guangdong) Biotechnology Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Guanjiuzhao (Guangdong) Biotechnology Co., Ltd. file in?
Guanjiuzhao (Guangdong) Biotechnology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 32 (Light Beverages). Class 32 covers beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages.
What are Guanjiuzhao (Guangdong) Biotechnology Co., Ltd.'s most well-known trademarks?
Guanjiuzhao (Guangdong) Biotechnology Co., Ltd.'s registered trademark portfolio includes well-known marks such as FLAXWELL. These are among 1 currently registered trademark in the portfolio.
What is Guanjiuzhao (Guangdong) Biotechnology Co., Ltd.'s trademark registration success rate?
Guanjiuzhao (Guangdong) Biotechnology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.